(NYSE: SOLV) Solventum's forecast annual revenue growth rate of 0.02% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 9.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.8%.
Solventum's revenue in 2025 is $8,308,000,000.On average, 4 Wall Street analysts forecast SOLV's revenue for 2025 to be $1,456,850,465,339, with the lowest SOLV revenue forecast at $1,428,048,658,188, and the highest SOLV revenue forecast at $1,472,580,627,195. On average, 4 Wall Street analysts forecast SOLV's revenue for 2026 to be $1,428,861,645,908, with the lowest SOLV revenue forecast at $1,354,984,782,189, and the highest SOLV revenue forecast at $1,489,641,258,420.
In 2027, SOLV is forecast to generate $1,448,250,165,999 in revenue, with the lowest revenue forecast at $1,404,223,048,699 and the highest revenue forecast at $1,523,897,816,976.